Skip to main content

Holocene Advisors, LP

SEC CIK
0001700574
Latest filing
Aug 14, 2026

SYRE holding history

Spyre Therapeutics, Inc. in every 13F filed by Holocene Advisors, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SYRE overviewAll 13F holders of SYREFull Q2 2026 holdings

Shares (Q2 2026)
1,015,170
Value
$90.1M
% of portfolio
0.2%
Quarters held
1
Since Q2 2026
Holdings of SYRE by Holocene Advisors, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,015,170$90.1M0.2%+1,015,170NewHolders